Clinical trials · Washington, D.C., DC
Pediatric ALL clinical trials in Washington, D.C.
We’re tracking 119 recruiting pediatric all studies with a site in or near Washington, D.C. — including Early Phase 1, Phase 1, Phase 1/Phase 2, Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Washington, D.C.
- NCT05966311Recruiting
Ultrasound-guided feeding tube placement for children
This study tests a new way to place a feeding tube directly into the stomach using ultrasound instead of an endoscope. It may be a safer and less invasive option for children who need help getting nutrition.
Washington D.C., District of ColumbiaAges birth–21 years - NCT05528939Recruiting
Training attention skills for children after cancer
This trial tests a computer-based “attention-control training” program to see if it’s doable and helpful for children who finished treatment for acute lymphoblastic leukemia or a brain tumor. It also looks at how acceptable the program is for both kids and caregivers.
Washington D.C., District of ColumbiaAges 8–16 - NCT05550298Recruiting
Study of virus infections after pediatric transplants
This study looks at how respiratory viruses behave and how the body responds in children who are about to receive, or have recently received, a transplant. It may help doctors better diagnose and treat viral infections in transplant patients by studying blood samples and test results.
Washington D.C., District of ColumbiaAges Up to 18 years - NCT05610787Enrolling by invitation
Testing a device that helps move an EXCOR pediatric heart pump
This trial studies an “active driving” system that controls the EXCOR pediatric heart pump. It’s meant for children who need a heart pump as a bridge to heart transplantation, to help the pump work more safely and effectively.
Washington D.C., District of ColumbiaAges Up to 21 years - NCT04743141RecruitingPhase 3
Long-term migraine medicine study for kids with migraine attacks
This Phase 3 study checks the long-term safety of rimegepant, a migraine treatment, in children and teens. You might join if your child has had migraine for at least 6 months and still gets a certain number of moderate-to-severe migraine attacks.
Washington D.C., District of ColumbiaAges 6–17 - NCT05609630RecruitingPhase 3
Testing two medicines for active systemic juvenile arthritis
This Phase 3 trial studies how well upadacitinib (a pill) and tocilizumab (a shot/IV medicine) improve symptoms and inflammation in children with active systemic juvenile idiopathic arthritis (sJIA). It also looks at side effects and how these medicines move through the body.
Washington D.C., District of ColumbiaAges 1–17 - NCT06607627RecruitingPhase 3
Testing gefurulimab in children with generalized myasthenia gravis
This study tests a new drug called gefurulimab in children and teens with generalized myasthenia gravis (a disease that causes muscle weakness). It looks at how safe and effective the drug is, and how it works in the body.
Washington D.C., District of ColumbiaAges 6–17 - NCT05267821RecruitingPhase 2/Phase 3
Testing anakinra to reduce inflammation in pediatric sepsis MODS
This study tests whether a medicine called anakinra can “turn down” harmful inflammation in children with severe illness from sepsis. It aims to improve organ function when multiple organs are starting to fail.
Washington D.C., District of ColumbiaAges 1 day–17 years - NCT05135975RecruitingPhase 2
Cabozantinib maintenance to help stop pediatric cancer from growing
This trial studies cabozantinib given after standard treatment to try to keep high-risk pediatric solid tumors from coming back or getting worse. It is offered to children and young adults whose cancer has not fully disappeared but is not progressing at the start of this maintenance phase.
Washington D.C., District of ColumbiaAges 1.5 years–40 years - NCT06036199Recruiting
Focused ultrasound for movement problems in cerebral palsy
This trial tests if focused ultrasound can help reduce uncontrolled movements in children and young adults with cerebral palsy caused by a lack of oxygen at birth. It may offer an option for those whose current medications aren't working well enough.
Washington D.C., District of ColumbiaAges 8–22 - NCT06712875RecruitingPhase 1/Phase 2
Brain cancer drug combo for kids with BRAF mutations
This trial tests a combination of targeted therapy (dabrafenib and trametinib) and immunotherapy (nivolumab) for children and young adults with certain BRAF gene changes in their glioma. It aims to see if this drug combination can shrink tumors or stop them from growing.
Washington D.C., District of ColumbiaAges 1–26 - NCT06722638Recruiting
Virtual reality for lumbar punctures in leukemia
This study tests if using a virtual reality headset during a lumbar puncture (a spinal tap) can help children feel less pain and anxiety. It is for children with acute lymphoblastic leukemia (ALL) or lymphoma who are in the maintenance phase of treatment.
Washington D.C., District of ColumbiaAges 7 years+ - NCT04775485RecruitingPhase 2
Targeted medicine for children with certain brain or solid tumors
This Phase 2 study tests tovorafenib, a targeted cancer medicine, in children and young adults whose tumors have specific BRAF or RAF changes. It is for cancers that have come back or grown despite previous treatment, with measurable signs on scans.
Washington D.C., District of ColumbiaAges 6 months–25 years - NCT07124078RecruitingPhase 2
Study of axatilimab for young people with chronic graft-versus-host disease
This study tests a new drug called axatilimab for children and teens with chronic graft-versus-host disease (cGVHD) that hasn't improved with standard treatments. The goal is to see if axatilimab works better than the usual care options. Participants will be randomly assigned to receive either axatilimab or one of several standard treatments.
Washington D.C., District of ColumbiaAges 2–17 - NCT07402837Enrolling by invitation
Flexible teaching tool for pediatric palliative care learners
This study is creating a teaching tool for healthcare professionals who rotate through pediatric palliative care. If you've spent at least half a day with the team, you can help shape how future learners are trained.
Silver Spring, MarylandAges 18 years+ - NCT05656378Recruiting
Storing samples to study how the body interacts with microbes
This study creates a storage bank of biological samples like blood, stool, and tissue. Researchers will use these samples to learn how the body interacts with the natural microbes that live in and on us, which may help improve treatments for many diseases.
Bethesda, MarylandAges Any age - NCT05052216Recruiting
Wearable monitor study for kids’ sleep apnea
This study tests a wearable device that can help monitor breathing and sleep in children. It compares children with sleep apnea to children without sleep apnea using a simple nighttime monitoring approach.
Bethesda, MarylandAges 3–12 - NCT07489378Recruiting
Rare cancer registry for children and young adults
This trial is creating a registry for very rare solid tumors in people up to age 39. Joining helps doctors learn more about these cancers and may connect you with future research opportunities.
Bethesda, MarylandAges 1 month–120 years - NCT03831958Recruiting
Follow-up study of children cured of Cushing disease
This study checks long-term health in people who were treated successfully for Cushing disease when they were under 21. It also collects information from family members to study genetic links to pituitary tumors.
Bethesda, MarylandAges 2–90 - NCT06595953RecruitingPhase 2
Music therapy with CBT for child anxiety
This study tests if adding a special music therapy that responds to where your child looks during cognitive behavioral therapy (CBT) can help reduce anxiety better than CBT alone. It is designed for children 8–17 with separation, generalized, or social anxiety.
Bethesda, MarylandAges 8–17 - NCT00025935Recruiting
Brain function study in children with mood problems
This study looks at how the brain works and how mood disorders change over time in children and teens with severe irritability, anger, and temper outbursts. It includes brain scans and regular check-ins to understand the illness better.
Bethesda, MarylandAges 7–85 - NCT04222413RecruitingPhase 1
Study of metarrestin for advanced solid tumors
This study tests an experimental drug called metarrestin for people with solid tumors that have spread or come back after standard treatment. It may help by targeting a protein involved in cancer cell growth.
Bethesda, MarylandAges 12–120 - NCT07696065RecruitingEarly Phase 1
Palliative care support for kids in early cancer trials
This study tests adding palliative care—extra comfort and quality-of-life support—for children and young adults being considered for early-phase cancer trials. It involves patients, their families, and their doctors.
Bethesda, MarylandAges birth–25 years - NCT00018057RecruitingPhase 2
Brain study of pediatric anxiety disorders
This study looks at how the brain works in children and adults with anxiety disorders. It uses brain scans (fMRI) and other safe tests to understand anxiety better.
Bethesda, MarylandAges 8–65
Hear when a new Pediatric ALL trial opens near Washington, D.C., DC
We’ll email you when one opens near Washington, D.C., DC — at most once a week, no account needed, unsubscribe anytime.
Pediatric ALL trials in other cities
Where these studies are running near Washington, D.C.
Institutions with a site for the recruiting pediatric all studies listed above.
- National Institutes of Health Clinical Center · 8 studies
- Children's National Hospital · 5 studies
- Children's National Medical Center · 5 studies
- Children's National
- Children's National Medical
- Childrens National Hospital
- Childrens National Medical Center /ID# 253344
- Johns Hopkins University
What taking part in a pediatric all study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting pediatric all studies in District of Columbia.
Common questions
- Are there pediatric all clinical trials near Washington, D.C.?
- Yes. We're currently tracking 119 recruiting pediatric all studies with a site near Washington, D.C., each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a pediatric all study near Washington, D.C.?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Washington, D.C. to take part?
- Not necessarily. These studies have a site near Washington, D.C., but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a pediatric all trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New pediatric all studies open near Washington, D.C. regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.